1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 1995 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File NO. 0-15242 DURAMED PHARMACEUTICALS, INC. State of Incorporation - Delaware IRS Employer I.D. No. 11-2590026 7155 East Kemper Road Cincinnati, Ohio 45249 (513) 731-9900 Indicate by checkmark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months, and (2) has been subject to such filing requirements for the past 90 days. YES X NO ------ ------ Common Stock, $.01 par value per share: Shares Outstanding as of June 30, 1995 8,046,743 Page 1 of 20 pages